IL90028A0 - Solid microparticles containing fatty acids,contrast medium containing the same and kits for the preparation thereof - Google Patents

Solid microparticles containing fatty acids,contrast medium containing the same and kits for the preparation thereof

Info

Publication number
IL90028A0
IL90028A0 IL90028A IL9002889A IL90028A0 IL 90028 A0 IL90028 A0 IL 90028A0 IL 90028 A IL90028 A IL 90028A IL 9002889 A IL9002889 A IL 9002889A IL 90028 A0 IL90028 A0 IL 90028A0
Authority
IL
Israel
Prior art keywords
kits
preparation
fatty acids
same
contrast medium
Prior art date
Application number
IL90028A
Other versions
IL90028A (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL90028A0 publication Critical patent/IL90028A0/en
Publication of IL90028A publication Critical patent/IL90028A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic

Abstract

Contrast agents for ultrasonic diagnosis consisting of gas bubbles and microparticles are described and are characterised in that they contain as microparticles a mixture of at least one (C10-C20)-fatty acid with at least one solid which has no interfacial activity, suspended in a liquid vehicle. They provide contrast in ultrasonic imaging of the right and left heart, the myocardium and other organs such as the liver, spleen and kidney, after intravenous administration.
IL90028A 1988-10-07 1989-04-19 Solid microparticles containing fatty acids, contrast medium containing the same and kits for the preparation thereof IL90028A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3834705A DE3834705A1 (en) 1988-10-07 1988-10-07 ULTRASONIC CONTRASTING AGENTS FROM GAS BUBBLES AND MICROPARTICLES CONTAINING FATTY ACID

Publications (2)

Publication Number Publication Date
IL90028A0 true IL90028A0 (en) 1989-12-15
IL90028A IL90028A (en) 1993-01-31

Family

ID=6364930

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90028A IL90028A (en) 1988-10-07 1989-04-19 Solid microparticles containing fatty acids, contrast medium containing the same and kits for the preparation thereof

Country Status (19)

Country Link
EP (1) EP0365467B1 (en)
JP (1) JPH0737394B2 (en)
KR (1) KR970001433B1 (en)
CN (1) CN1027575C (en)
AT (1) ATE93145T1 (en)
AU (1) AU627456B2 (en)
CA (1) CA1338507C (en)
DE (2) DE3834705A1 (en)
DK (1) DK99789A (en)
ES (1) ES2059814T3 (en)
FI (1) FI100170B (en)
IE (1) IE65243B1 (en)
IL (1) IL90028A (en)
LU (1) LU90004I2 (en)
NL (1) NL970009I2 (en)
NO (2) NO178139C (en)
NZ (1) NZ228781A (en)
PT (1) PT91523B (en)
ZA (1) ZA892885B (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2112109A1 (en) * 1991-07-05 1993-01-21 Arne Berg Improvements in or relating to contrast agents
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
DE605477T1 (en) * 1991-09-17 1998-09-24 Sonus Pharma Inc GASEOUS ULTRASONIC CONTRASTING AGENTS AND METHOD FOR SELECTING GASES FOR USE AS ULTRASONIC CONTRASTING AGENTS.
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
MX9205298A (en) * 1991-09-17 1993-05-01 Steven Carl Quay GASEOUS ULTRASOUND CONTRASTING MEDIA AND METHOD FOR SELECTING GASES TO BE USED AS ULTRASOUND CONTRASTING MEDIA
US5196183A (en) * 1991-12-04 1993-03-23 Sterling Winthrop Inc. Contrast agents for ultrasound imaging
GB9200387D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
DE69427185T2 (en) 1993-01-25 2001-12-06 Sonus Pharma Inc Phase-pen colloids for use as ultrasound contrast agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
GB9402867D0 (en) * 1994-02-15 1994-04-06 Nycomed Imaging As Improvements in or relating to contrast agents
DE4406474A1 (en) * 1994-02-23 1995-08-24 Schering Ag Gas-containing microparticles, agents containing them, their use in ultrasound diagnostics, and methods for producing the particles and agents
US5876697A (en) * 1994-08-04 1999-03-02 Gakko Houjin Toin Gakuen Method for the production of microbubble-type ultrasonic contrast agent using fatty acid surfactants
DE19602930A1 (en) * 1996-01-18 1997-07-24 Schering Ag Porous matrices made of low molecular weight substances for the generation of stable gas bubble suspensions, their use as ultrasound contrast agents and processes for their production
GB9808582D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
JP2002527410A (en) 1998-10-12 2002-08-27 マリンクロッド・インコーポレイテッド New ultrasonic contrast agent
DE19950311A1 (en) * 1999-10-13 2001-04-19 Schering Ag Stable storage of parenteral ultrasonic contrast agent formulation, using vial closed with dry stopper to prevent reduction of in vivo effectiveness
DE19952738A1 (en) * 1999-10-27 2001-05-23 Schering Ag Improved suspensions of ultrasound contrast media
EP2279757A3 (en) 2000-06-02 2011-08-03 Bracco Suisse SA Compounds for targeting endothelial cells
ATE376803T1 (en) 2001-04-06 2007-11-15 Bracco Research Sa DEVICE FOR MEASURING LOCAL PHYSICAL PARAMETERS IN A LIQUID-FILLED CAVITY
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
AU2003278807A1 (en) 2002-03-01 2004-08-13 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
EP1572724A4 (en) 2002-03-01 2007-03-14 Dyax Corp Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
HUE039154T2 (en) 2003-03-03 2018-12-28 Dyax Corp Peptides that specifically bind HGF receptor (cMet) and uses thereof
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
KR101001547B1 (en) 2004-01-28 2010-12-17 삼성에스디아이 주식회사 A fabric solar cell and a method for preparing the same
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
JP5196896B2 (en) * 2007-07-13 2013-05-15 花王株式会社 Method for producing fine bubble precursor
WO2021141595A1 (en) * 2020-01-10 2021-07-15 Advanced Microbubbles Laboratories Llc Preparation and preservation of collagen microbubbles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640271A (en) 1969-06-30 1972-02-08 Ibm Blood flow pressure measurement technique employing injected bubbled and ultrasonic frequency scanning
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4265251A (en) 1979-06-28 1981-05-05 Rasor Associates, Inc. Method of determining pressure within liquid containing vessel
EP0052575B1 (en) 1980-11-17 1986-01-08 Schering Aktiengesellschaft Composition generating microbubbles
DE3141641A1 (en) 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen ULTRASONIC CONTRAST AGENTS AND THEIR PRODUCTION
JPS5920532A (en) * 1982-07-23 1984-02-02 Nippon Denso Co Ltd Method of controlling quantity of fuel for internal combustion engine on vehicle
DE3313947A1 (en) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS
DE3313946A1 (en) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS
DE3637926C1 (en) * 1986-11-05 1987-11-26 Schering Ag Ultrasonic manometry in a liquid using microbubbles

Also Published As

Publication number Publication date
ZA892885B (en) 1990-12-28
CN1027575C (en) 1995-02-08
FI100170B (en) 1997-10-15
CN1044225A (en) 1990-08-01
EP0365467A3 (en) 1990-06-06
FI890749A (en) 1990-04-08
DK99789A (en) 1990-04-08
NL970009I2 (en) 1997-08-01
JPH0737394B2 (en) 1995-04-26
NO890609D0 (en) 1989-02-13
NO178139C (en) 1996-01-31
NO1998014I1 (en) 1998-05-05
NO178139B (en) 1995-10-23
IE891149L (en) 1990-04-07
DE58905318D1 (en) 1993-09-23
AU3390089A (en) 1990-04-12
NO890609L (en) 1990-04-09
DE3834705A1 (en) 1990-04-12
ES2059814T3 (en) 1994-11-16
JPH02145528A (en) 1990-06-05
KR970001433B1 (en) 1997-02-06
IE65243B1 (en) 1995-10-04
CA1338507C (en) 1996-08-06
EP0365467B1 (en) 1993-08-18
FI890749A0 (en) 1989-02-16
DK99789D0 (en) 1989-03-01
IL90028A (en) 1993-01-31
ATE93145T1 (en) 1993-09-15
EP0365467A2 (en) 1990-04-25
AU627456B2 (en) 1992-08-27
NZ228781A (en) 1992-03-26
NL970009I1 (en) 1997-05-01
KR900005939A (en) 1990-05-07
LU90004I2 (en) 1997-03-04
PT91523B (en) 1995-05-31
PT91523A (en) 1990-04-30

Similar Documents

Publication Publication Date Title
IL90028A (en) Solid microparticles containing fatty acids, contrast medium containing the same and kits for the preparation thereof
Walsh et al. Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia
ATE96661T1 (en) SOFT GELATIN CAPSULES AND PROCESS FOR THEIR MANUFACTURE.
CN1168636A (en) Liposomal agents
DE3313947A1 (en) MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS
NZ207853A (en) Ultrasound contrast agent containing microparticles and gas micro-bubbles
CA2211100A1 (en) Diagnostic imaging contrast agents with extended blood retention
EP1394256A3 (en) HCV genomic sequences for diagnostics and therapeutics
FR2385403B1 (en)
ATE80801T1 (en) ANTITUMORS COMPOSITIONS CONTAINING A REACTION PRODUCT BETWEEN A CYTOTOXIC ALDEHYDE AND PENICILLAMIN AND THEIR USE IN THE MANUFACTURE OF PHARMACEUTICALS.
Besa et al. Aetiocholanolone and prednisolone therapy in patients with severe bone-marrow failure
ATE59035T1 (en) BASIC SUBSTITUTED BENZOFURANCARBONIC ACIDS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM.
Chaudhuri et al. Uptake of 87mSr by liver metastasis from carcinoma of colon
Roth et al. Lipemia-Induced Acceleration of Intravascular Clotting.
CA2031191A1 (en) Composition of beneficial agent and method for administering the same by controlled dissolution
Aramaki et al. Selective incorporation of asialofetuin into hepatocyte of rat
SU1159533A1 (en) Liquid for preserving anatomic preparations
Weinstein et al. The requirement of free fatty acids for the fatty liver of CCl4 intoxication
KR20020052072A (en) Contrast agent and manufacturing method of same
ENEMAS be taught is diminishing, partly as increasing
Dhopeshwarkar et al. Blood-Brain Barrier System
Galera-Davidson et al. Disseminated intravascular coagulation in Wistar rats.
JPS59148735A (en) Ubidecarenone composition
LEE et al. An Experimental Study on the Effect of Mixture of Absolute Ethanol and Lipiodol Injected into Normal Liver ofRabbit: CT Features and Histopathologic Changes
RU92004556A (en) CONTRAST SUBSTANCE FOR ULTRASOUND DIAGNOSTICS AND METHOD OF OBTAINING IT

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force